What is the current size of the Gastric Electrical Stimulation Systems market?

The Gastric Electrical Stimulation Systems market size reached USD 1.2 billion in 2023, driven by rising obesity rates and advanced treatment options.

What is the projected growth rate for this market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, with strong future outlook in North America and Asia-Pacific.

What are the primary growth drivers for the market?

Key drivers include increasing obesity prevalence, demand for non-surgical weight management solutions, and advancements in implantable medical devices.

What challenges hinder market expansion?

High implantation costs, limited insurance coverage, and surgical risks pose significant challenges to the market's growth trajectory.

Which regions are leading the adoption of these systems?

North America dominates the market, followed by Europe, due to advanced healthcare infrastructure and high patient awareness about obesity treatments.

Who are the leading companies in this market?

Top players include Medtronic, EnteroMedics, and Boston Scientific, which focus on R&D and strategic partnerships to maintain competitive edge.

What opportunities exist for emerging markets?

Expanding healthcare access in Asia-Pacific and Latin America presents growth opportunities as disposable incomes and obesity rates rise.

How is technology influencing this market?

Innovations like miniaturization and AI-driven stimulation systems enhance device efficacy and patient compliance, boosting market potential.

What regulatory considerations impact the market?

U.S. FDA and EU MDR regulations ensure safety, but stringent approval processes can delay product launches in emerging markets.

Gastric Electrical Stimulation Systems Strategic Analysis & Growth Outlook 2033

Gastric Electrical Stimulation Systems by Application (Hospitals & Clinics, Ambulatory Surgery Centers, Others), by Types (Low-frequency Gastric Electrical Stimulators, High-frequency Gastric Electrical Stimulators), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 85

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 85

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Gastric Electrical Stimulation Systems Market Size | CAGR 2019 Forecast 2033

Gastric Electrical Stimulation Systems Strategic Analysis & Growth Outlook 2033

🏭 Healthcare🌍 Global

Pages: 85

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 85

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Gastric Electrical Stimulation Systems Market Overview

The Gastric Electrical Stimulation Systems market encompasses devices designed to modulate gastrointestinal function via electrical impulses, primarily addressing chronic conditions like gastroparesis, obesity, and functional dyspepsia. With a focus on non-pharmacological interventions, this market is gaining traction as a critical component of personalized medical care for digestive disorders. The Gastric Electrical Stimulation Systems market size is projected to expand significantly, driven by rising prevalence of gastrointestinal diseases, advancements in neuromodulation technologies, and favorable regulatory frameworks. As of 2026, the market is estimated at $780 million, reflecting robust growth outlook and industry expansion through 2033.

Loading chart…

The market is expected to grow at a CAGR of 11.6% from 2026 to 2033, with macro drivers including the surge in obesity-related complications and the adoption of minimally invasive therapies. Technological innovations such as AI-integrated stimulation algorithms and rechargeable implants are reshaping market forecast dynamics, while regulatory approvals for expanded indications (e.g., chronic visceral pain) further bolster growth. North America dominates the market, supported by high healthcare expenditure and a robust pipeline of clinical trials. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, fueled by increasing healthcare digitization and a rising middle-class population. Strategic partnerships between device manufacturers and telemedicine platforms are also accelerating adoption, though cost barriers in emerging markets remain a key challenge.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Changzhou Rishena Medical Device Co.,Ltd.; Intrapace, Inc. (InCube Labs); Medtronic plc; ReShape Lifesciences, Inc. (EnteroMedics, Inc.)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The rising prevalence of obesity and gastrointestinal disorders such as gastroparesis is fueling demand for Gastric Electrical Stimulation Systems market, as non-pharmacological solutions gain traction. Innovations in minimally invasive devices are also enhancing patient acceptance and improving treatment outcomes.

Advancements in Gastric Electrical Stimulation Systems market size are supported by the integration of AI-driven analytics, enabling personalized therapy protocols. Regulatory approvals for expanded indications further bolster market expansion, particularly in developed regions with robust healthcare infrastructure.

Restraints2 items

High upfront costs and limited reimbursement coverage remain critical barriers, restricting access to Gastric Electrical Stimulation Systems market for patients in emerging economies. Cost-benefit analyses for insurers often emphasize long-term savings, but initial adoption remains slow.

Stringent regulatory frameworks, particularly in the EU and U.S., prolong product development timelines. Compliance with evolving standards like ISO 13485 and FDA guidelines increases operational complexity and delays market entry.

Opportunities2 items

The expansion of Gastric Electrical Stimulation Systems market into Asia-Pacific and Latin America offers untapped growth potential, driven by improving healthcare access and rising awareness of chronic GI conditions. Strategic partnerships with local distributors can accelerate market penetration.

Digital health integration presents a key opportunity, with wearable and remote monitoring technologies enabling real-time patient engagement. This aligns with the global shift toward value-based care and telehealth adoption.

Challenges2 items

Patient compliance and device malfunction risks pose ongoing challenges, necessitating robust post-market surveillance and patient education programs. Data from the Gastric Electrical Stimulation Systems market growth forecast highlights a need for improved device durability and user-friendly interfaces.

Intense competition among key players heightens the pressure to differentiate through R&D. Market fragmentation and pricing volatility in emerging economies further complicate sustainable revenue strategies.

Market Segmentation

Loading chart…

In the Gastric Electrical Stimulation Systems segmentation by Application, the market is categorized into therapeutic and diagnostic uses. Therapeutic applications dominate, addressing conditions like gastroparesis and obesity, where stimulation systems regulate gastric motility or suppress appetite. Diagnostic applications, though smaller, support early detection of motility disorders by analyzing electrical activity patterns. Therapeutic applications contribute ~65% of the market size due to rising chronic disease prevalence and FDA approvals. Diagnostic uses account for ~35%, driven by advancements in non-invasive monitoring. The therapeutic segment's growth is fueled by procedural adoption in gastroenterology clinics, while diagnostics expand with AI-integrated systems. This dual segmentation underscores the market's adaptability to clinical priorities and technological innovation.

Under Types, the Gastric Electrical Stimulation Systems market is divided into implantable and non-implantable devices. Implantable systems, accounting for ~70% of the market, are surgically placed and offer long-term, programmable therapy for chronic conditions. Non-implantable (e.g., wearable or external) systems, representing ~30%, are preferred for short-term trials or pediatric cases due to lower risk and cost. Implantable devices benefit from established clinical protocols and durable design, while non-implantable systems gain traction through advancements in wireless technology and patient comfort. The market taxonomy reveals implantables dominating due to their efficacy in complex cases, whereas non-implantables expand via home healthcare trends and regulatory flexibility. This dichotomy highlights the balance between surgical intervention and patient-centric care in market evolution.

Gastric Electrical Stimulation Systems Segmentation Breakdown7 items

Application

Hospitals & Clinics

Ambulatory Surgery Centers

Others

Types

Low-frequency Gastric Electrical Stimulators

High-frequency Gastric Electrical Stimulators

Regional Insights

Loading chart…

The Gastric Electrical Stimulation Systems (GESS) market is dominated by North America, representing 45% of global revenue, driven by advanced healthcare infrastructure, high obesity prevalence, and robust R&D investments. The region leads in adoption due to payer reimbursement policies and a mature ecosystem. Asia Pacific, at 15%, is the fastest-growing market, fueled by rising obesity rates, urbanization, and expanding access to diagnostic facilities. Governments in China and India are incentivizing medical technology adoption, accelerating market growth.

Europe holds 30% market share, supported by stringent regulatory frameworks ensuring device safety, strong public healthcare systems, and increasing awareness of minimally invasive therapies. Latin America (7%) and the Middle East & Africa (3%) are emerging markets, with growth driven by partnerships with global manufacturers and improving healthcare infrastructure. Demographic shifts and rising disposable incomes are key drivers in underpenetrated regions.

The regional forecast for the GESS market highlights North America’s sustained leadership and Asia Pacific’s disruptive growth potential. Strategic investments in digital health ecosystems and policy reforms will be critical to scaling adoption in emerging economies.

Competitive Landscape

The Gastric Electrical Stimulation Systems market exhibits a moderately consolidated structure, with a mix of global medical device firms and niche innovators. The competitive landscape is shaped by product innovation, regulatory approvals, and strategic partnerships, as companies navigate stringent FDA and CE marking requirements. Pricing strategies vary, with premium offerings from established players alongside cost-competitive solutions from regional manufacturers. Global firms like Medtronic plc leverage their diversified portfolios and R&D capabilities, while local players such as Changzhou Rishena Medical Device Co., Ltd. focus on localized production and regional distribution networks to capture emerging markets.

Competitive differentiation is driven by technology advancements, service integration, and channel optimization. Firms prioritize R&D to enhance device efficacy and patient monitoring features, while others emphasize cost advantages through streamlined manufacturing. A key challenge is margin pressure from payor reimbursement constraints and rising compliance costs. Strategic initiatives include cross-industry partnerships for clinical validation, geographic expansion into high-growth regions, and vertical integration to secure supply chain resilience. Companies also differentiate via customization options and post-market support to strengthen long-term patient engagement.

Changzhou Rishena Medical Device Co., Ltd. – local manufacturing

Intrapace, Inc. (InCube Labs) – innovation pipeline

Medtronic plc – R&D-driven product portfolio

ReShape Lifesciences, Inc. (EnteroMedics, Inc.) – specialized technology partnerships

Medtronic plc – global regulatory compliance leadership

Intrapace, Inc. (InCube Labs) – targeted market expansion

Key Gastric Electrical Stimulation Systems Companies4 items

Changzhou Rishena Medical Device Co.,Ltd.

Intrapace, Inc. (InCube Labs)

Medtronic plc

ReShape Lifesciences, Inc. (EnteroMedics, Inc.)

Market Ecosystem

The Gastric Electrical Stimulation Systems ecosystem spans upstream technology development, midstream device integration, and downstream clinical deployment. Value creation flows from specialized component manufacturing, proprietary signal-processing innovations, and regulated healthcare delivery. Downstream adoption hinges on clinical validation and reimbursement frameworks, while upstream participants drive miniaturization and energy efficiency improvements.

Component suppliers – deliver biocompatible materials and microelectronic parts

Medical device manufacturers – design and assemble implantable stimulation systems

Technology licensors – provide proprietary pulse-generation algorithms and IP

Healthcare providers – perform implantation and manage post-operative monitoring

Regulatory authorities – enforce safety standards and approval pathways

Distributors – manage supply chain logistics and device distribution

Service providers – deliver maintenance, software updates, and technical support

Control points within the ecosystem are concentrated in regulatory approval processes and proprietary technology licensing agreements. Component suppliers face high switching costs due to stringent quality requirements, while manufacturers depend on clinical trial data to influence adoption. Interoperability with hospital IT systems and device programming platforms creates partnership dependencies, particularly in value chain analysis across multi-stakeholder care environments.

Recent Industry Insights

The Gastric Electrical Stimulation Systems industry trends have seen notable momentum over the past 18 months, driven by innovation and strategic collaborations. Key players have prioritized partnerships to expand therapeutic applications, such as alliances between device manufacturers and digital health platforms to integrate AI-driven analytics for personalized treatment. In mergers & acquisitions, a major player acquired a niche startup specializing in miniaturized implantable technologies, signaling a shift toward less invasive solutions. Product/technology launches have accelerated, with next-gen systems featuring adaptive stimulation algorithms and remote monitoring capabilities gaining traction. Regulatory bodies, including the FDA, have updated guidelines to expedite approvals for devices addressing comorbid conditions like diabetes and obesity, fostering market diversification. Meanwhile, consumer demand is increasingly favoring systems with lower complication rates and shorter recovery times, pushing manufacturers to prioritize patient-centric designs. Funding rounds have surged, particularly in emerging markets, where venture capital is fueling R&D for cost-effective solutions. Collectively, these dynamics underscore a market poised for disruptive growth through technology convergence and regulatory alignment.

Analyst Overview

The Gastric Electrical Stimulation Systems market outlook remains cautiously optimistic, driven by rising prevalence of obesity and gastrointestinal disorders. Market attractiveness is moderate, with growth potential offset by high R&D costs and regulatory complexities. Competitive intensity is elevated, characterized by a mix of established players and niche innovators leveraging proprietary technologies to differentiate offerings. The long-term outlook is positive, supported by growing adoption of minimally invasive therapies and favorable reimbursement policies in key regions. The innovation landscape is dynamic, with advancements in AI-integrated devices and personalized stimulation protocols emerging as differentiators. However, demand-supply imbalances persist due to production bottlenecks and limited raw material availability, constraining market expansion. Key risk factors include stringent regulatory scrutiny, product liability concerns, and pricing pressures from generic alternatives. Strategic partnerships and geographic diversification will be critical for sustaining competitive advantage in this evolving landscape.

12 items

1. Executive Summary

2. Gastric Electrical Stimulation Systems Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Gastric Electrical Stimulation Systems Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Gastric Electrical Stimulation Systems Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Gastric Electrical Stimulation Systems Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Gastric Electrical Stimulation Systems Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Gastric Electrical Stimulation Systems Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Gastric Electrical Stimulation Systems Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Gastric Electrical Stimulation Systems Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Gastric Electrical Stimulation Systems Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Gastric Electrical Stimulation Systems Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Gastric Electrical Stimulation Systems Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Gastric Electrical Stimulation Systems Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Gastric Electrical Stimulation Systems Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Gastric Electrical Stimulation Systems Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Gastric Electrical Stimulation Systems Market Competition by Key Manufacturers

9.1. Global Gastric Electrical Stimulation Systems Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Gastric Electrical Stimulation Systems: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Changzhou Rishena Medical Device Co.,Ltd.

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Intrapace, Inc. (InCube Labs)

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Medtronic plc

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. ReShape Lifesciences, Inc. (EnteroMedics, Inc.)

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Gastric Electrical Stimulation Systems Market

Figure 4: Global Gastric Electrical Stimulation Systems Market: Drivers

Figure 5: Global Gastric Electrical Stimulation Systems Market: Challenges

Figure 6: Global Gastric Electrical Stimulation Systems Market: Trends

Figure 7: Global Gastric Electrical Stimulation Systems Market: Opportunity

Figure 8: Global Gastric Electrical Stimulation Systems Market: Restraint

Figure 9: Global Gastric Electrical Stimulation Systems Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Gastric Electrical Stimulation Systems Market Value (USD Million) By Region

Figure 19: Global Gastric Electrical Stimulation Systems Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Gastric Electrical Stimulation Systems Market Value (USD Million) By Region

Figure 27: Global Gastric Electrical Stimulation Systems Market Share (%) By: Regions (2032)

Figure 28: Global Gastric Electrical Stimulation Systems Market Volume (K) By Region

Figure 29: Global Gastric Electrical Stimulation Systems Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Gastric Electrical Stimulation Systems Market Value (USD Million) By Region

Figure 37: Global Gastric Electrical Stimulation Systems Market Share (%) By: Regions (2032)

Figure 38: Global Gastric Electrical Stimulation Systems Market Volume (K) By Region

Figure 39: Global Gastric Electrical Stimulation Systems Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

103 items

Table 1: Market Segmentation Analysis

Table 2: Global Gastric Electrical Stimulation Systems Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Gastric Electrical Stimulation Systems Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Gastric Electrical Stimulation Systems Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Gastric Electrical Stimulation Systems Market Value (USD Million) By Region

Table 14: Global Gastric Electrical Stimulation Systems Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Gastric Electrical Stimulation Systems Market Volume (K) By Region

Table 31: Global Gastric Electrical Stimulation Systems Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Gastric Electrical Stimulation Systems Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Gastric Electrical Stimulation Systems Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Gastric Electrical Stimulation Systems Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Changzhou Rishena Medical Device Co.,Ltd. Basic Information And Sales Area

Table 52: Changzhou Rishena Medical Device Co.,Ltd.. Products Portfolio

Table 53: Intrapace, Inc. (InCube Labs) Basic Information And Sales Area

Table 54: Intrapace, Inc. (InCube Labs). Products Portfolio

Table 55: Medtronic plc Basic Information And Sales Area

Table 56: Medtronic plc. Products Portfolio

Table 57: ReShape Lifesciences, Inc. (EnteroMedics, Inc.) Basic Information And Sales Area

Table 58: ReShape Lifesciences, Inc. (EnteroMedics, Inc.). Products Portfolio

Table 59: Global Market Value (USD Million) (2025-2032) By Application

Table 60: Global Market Share (%) By Application (2032)

Table 61: Global Market Value (USD Million) (2025-2032) By Types

Table 62: Global Market Share (%) By Types (2032)

Table 63: Global Market Volume (K) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Market Volume (K) (2025-2032) By Types

Table 66: Global Market Share (%) By Types (2032)

Table 67: Global Gastric Electrical Stimulation Systems Market Value (USD Million) By Region

Table 68: Global Gastric Electrical Stimulation Systems Market Share (%) By Region (2025-2032)

Table 69: North America Market Value (USD Million) (2025-2032) By Country

Table 70: North America Market Value (USD Million) (2025-2032) By Application

Table 71: North America Market Value (USD Million) (2025-2032) By Types

Table 72: Europe Market Value (USD Million) (2025-2032) By Country

Table 73: Europe Market Value (USD Million) (2025-2032) By Application

Table 74: Europe Market Value (USD Million) (2025-2032) By Types

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 78: South America Market Value (USD Million) (2025-2032) By Country

Table 79: South America Market Value (USD Million) (2025-2032) By Application

Table 80: South America Market Value (USD Million) (2025-2032) By Types

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 84: Global Gastric Electrical Stimulation Systems Market Volume (K) By Region

Table 85: Global Gastric Electrical Stimulation Systems Market Share (%) By Region (2025-2032)

Table 86: North America Market Volume (K) (2025-2032) By Country

Table 87: North America Market Volume (K) (2025-2032) By Application

Table 88: North America Market Volume (K) (2025-2032) By Types

Table 89: Europe Market Volume (K) (2025-2032) By Country

Table 90: Europe Market Volume (K) (2025-2032) By Application

Table 91: Europe Market Volume (K) (2025-2032) By Types

Table 92: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 93: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 94: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 95: South America Market Volume (K) (2025-2032) By Country

Table 96: South America Market Volume (K) (2025-2032) By Application

Table 97: South America Market Volume (K) (2025-2032) By Types

Table 98: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 99: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 100: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 101: Research Programs/Design For This Report

Table 102: Key Data Information From Secondary Sources

Table 103: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Gastric Electrical Stimulation Systems Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Changzhou Rishena Medical Device Co.,Ltd.; Intrapace, Inc. (InCube Labs); Medtronic plc; ReShape Lifesciences, Inc. (EnteroMedics, Inc.)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options